13 / 25
Page 68
conferenceseries
.com
Volume 8
Journal of Biotechnology & Biomaterials
ISSN: 2155-952X
Pharma Biotech 2018
December 10-11, 2018
December 10-11, 2018 | Rome, Italy
23
rd
International Conference on
Pharmaceutical Biotechnology
Ethnopharmacological surveyofmedicinalplantusedforthe treatmentof liverdamage,nephrolithiasis
and cardiovascular disease in the south region of Morocco, Marrakech
F Marhoume
1,2
, H Boufous
1,2
, M Ait Laardia
2
, A Chait
2
and
A Bagri
1
1
Hassan I University, Morocco
2
University Cadi Ayyad, Morocco
T
his studywas carriedout to identify thewidelyusedmedicinal plant in folkmedicine for treating liver damage, nephrolithiasis
and cardiovascular disease by the population of Marrakech province, in South of Morocco. This investigation was
undertaken during more than 4 months started in 2015. Data were collected from (54%) housewife, (63%) traditional healers
using ethnobotanical questionnaire. A total of 67% reported that
Rubia tinctorum
L. is the only plant used for the treatment and
management of the above-mentioned diseases. Data collected was separated in two parts. The first part concerned interviewee
information’s (age, sex, and level of education) and the second part was designed for plant uses (vernacular names, uses, parts
used, and mode of preparation). Use value (UV), fidelity level and family UV (FUV) were calculated. The dried root (57%)
of
Rubia tinctorum
L. was prepared in the form of raw condition (78%). Oral administration of the plant was most (90%)
common route of administration. Finally (96%) were reported that the plant has no side effects. The results of the study show
that
Rubia tinctorum
L. is used for the treatment and management of both common and specialized human diseases. Further
studies are needed to better understand the underlying mechanism behind it therapeutic actions.
marhoume.fatimazahra@gmail.comJ Biotechnol Biomater 2018, Volume 8
DOI: 10.4172/2155-952X-C8-110